The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Bowen's Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Bowen's Disease


Psychiatry related information on Bowen's Disease


High impact information on Bowen's Disease


Chemical compound and disease context of Bowen's Disease


Biological context of Bowen's Disease


Anatomical context of Bowen's Disease


Gene context of Bowen's Disease


Analytical, diagnostic and therapeutic context of Bowen's Disease


  1. Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth. Hiraiwa, A., Fujita, M., Nagasaka, T., Adachi, A., Ohashi, M., Ishibashi, M. Int. J. Cancer (1997) [Pubmed]
  2. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. Matsui, M., Nishigori, C., Toyokuni, S., Takada, J., Akaboshi, M., Ishikawa, M., Imamura, S., Miyachi, Y. J. Invest. Dermatol. (1999) [Pubmed]
  3. Telomerase activity in melanoma and non-melanoma skin cancer. Parris, C.N., Jezzard, S., Silver, A., MacKie, R., McGregor, J.M., Newbold, R.F. Br. J. Cancer (1999) [Pubmed]
  4. COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals. O'Grady, A., O'Kelly, P., Murphy, G.M., Leader, M., Kay, E. Hum. Pathol. (2004) [Pubmed]
  5. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. Wong, S.S., Tan, K.C., Goh, C.L. J. Am. Acad. Dermatol. (1998) [Pubmed]
  6. Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-kappa B and activator protein-1 activity. Liao, W.T., Chang, K.L., Yu, C.L., Chen, G.S., Chang, L.W., Yu, H.S. J. Invest. Dermatol. (2004) [Pubmed]
  7. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light. Takata, M., Rehman, I., Rees, J.L. Int. J. Cancer (1997) [Pubmed]
  8. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer. Sikkink, S.K., Rehman, I., Rees, J.L. J. Invest. Dermatol. (1997) [Pubmed]
  9. The expression of placental-type glutathione S-transferase (GST-pi) in human cutaneous carcinoma in situ, that is, actinic keratosis and Bowen's disease, compared with normal human skin. Shimizu, K., Toriyama, F., Zhang, H.M., Yoshida, H. Carcinogenesis (1995) [Pubmed]
  10. 5-fluorouracil iontophoretic therapy for Bowen's disease. Welch, M.L., Grabski, W.J., McCollough, M.L., Skelton, H.G., Smith, K.J., Menon, P.A., Anderson, L.L. J. Am. Acad. Dermatol. (1997) [Pubmed]
  11. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Hsu, Y.H., Li, S.Y., Chiou, H.Y., Yeh, P.M., Liou, J.C., Hsueh, Y.M., Chang, S.H., Chen, C.J. Mutat. Res. (1997) [Pubmed]
  12. Treatment of Bowen's disease of the digit with carbon dioxide laser. Tantikun, N. J. Am. Acad. Dermatol. (2000) [Pubmed]
  13. Treatment of multiple lesions of Bowen disease with isotretinoin and interferon alfa. Efficacy of combination chemotherapy. Gordon, K.B., Roenigk, H.H., Gendleman, M. Archives of dermatology. (1997) [Pubmed]
  14. Pigmented Bowen's disease. Papageorgiou, P.P., Koumarianou, A.A., Chu, A.C. Br. J. Dermatol. (1998) [Pubmed]
  15. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Saridaki, Z., Liloglou, T., Zafiropoulos, A., Koumantaki, E., Zoras, O., Spandidos, D.A. Br. J. Dermatol. (2003) [Pubmed]
  16. Cell surface carbohydrates in proliferative epidermal lesions. II. Masking of peanut agglutinin (PNA) binding sites in solar keratoses, Bowen's disease, and squamous cell carcinoma by neuraminic acid. Schaumburg-Lever, G., Alroy, J., Ucci, A., Lever, W.F. J. Cutan. Pathol. (1986) [Pubmed]
  17. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors. Matsumoto, M., Furihata, M., Kurabayashi, A., Ohtsuki, Y. Oncol. Rep. (2004) [Pubmed]
  18. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Grossman, D., McNiff, J.M., Li, F., Altieri, D.C. Lab. Invest. (1999) [Pubmed]
  19. Defective IL-2 receptor expression in lymphocytes of patients with arsenic-induced Bowen's disease. Yu, H.S., Chang, K.L., Yu, C.L., Wu, C.S., Chen, G.S., Ho, J.C. Arch. Dermatol. Res. (1998) [Pubmed]
  20. Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease. Zhang, X.M., Horiguchi, Y., Ueda, M., Yoshiki, T., Imamura, S. J. Dermatol. Sci. (1992) [Pubmed]
  21. Importance of human papillomaviruses for the development of skin cancer. Meyer, T., Arndt, R., Christophers, E., Nindl, I., Stockfleth, E. Cancer Detect. Prev. (2001) [Pubmed]
  22. Immunohistochemistry (S 100, KL 1) and human papillomavirus DNA hybridization on morbus Bowen and bowenoid papulosis. Hahn, A., Löning, T., Hoos, A., Henke, P. Virchows Archiv. A, Pathological anatomy and histopathology. (1988) [Pubmed]
  23. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease. Baum, H.P., Meurer, I., Unteregger, G. Br. J. Dermatol. (1994) [Pubmed]
  24. Immunohistochemical demonstration of carcinoembryonic antigen and related antigens in various cutaneous keratinous neoplasms and verruca vulgaris. Egawa, K., Honda, Y., Ono, T., Kuroki, M. Br. J. Dermatol. (1998) [Pubmed]
  25. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin. Okochi, H., Kato, M., Nashiro, K., Yoshie, O., Miyazono, K., Furue, M. Br. J. Dermatol. (1997) [Pubmed]
  26. Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. De Heller-Milev, M., Huber, M., Panizzon, R., Hohl, D. Br. J. Dermatol. (2000) [Pubmed]
  27. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. Park, H.R., Min, S.K., Cho, H.D., Kim, K.H., Shin, H.S., Park, Y.E. J. Cutan. Pathol. (2004) [Pubmed]
  28. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Hsu, C.H., Yang, S.A., Wang, J.Y., Yu, H.S., Lin, S.R. Br. J. Cancer (1999) [Pubmed]
  29. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Salim, A., Leman, J.A., McColl, J.H., Chapman, R., Morton, C.A. Br. J. Dermatol. (2003) [Pubmed]
  30. Pagetoid bowen disease: a report of 2 cases that express cytokeratin 7. Williamson, J.D., Colome, M.I., Sahin, A., Ayala, A.G., Medeiros, L.J. Arch. Pathol. Lab. Med. (2000) [Pubmed]
  31. Vulvar squamous cell carcinoma metastatic to the skin. Dudley, C., Kircik, L.H., Bullen, R., Snow, S., Landeck, A., Buchler, D. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. (1998) [Pubmed]
WikiGenes - Universities